The mRNA and protein expressions of KDM6B were significantly reduced in human NAFLD samples compared to the normal population, and fibroblast growth factor-21 (FGF21) improved hepatic autophagy and lipolysis through KDM6B in NAFLD mice [37]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.